Navigation Links
PRA Expert's Pulmonary Function Textbook Reissued
Date:8/2/2011

RALEIGH, N.C., Aug. 2, 2011 /PRNewswire/ -- PRA, a leading Clinical Research Organization, announces that the third edition of respiratory care expert Jack Wanger's book, Pulmonary Function Testing: A Practical Approach, has recently been published by Jones & Bartlett Learning in Sudbury, MA.

Mr. Wanger, Senior Clinical Research Scientist in PRA's Therapeutic Expertise group, wrote the textbook for both respiratory care students and practitioners and devotes each chapter to a separate pulmonary function test.  The topics explored in the book include spirometry, lung volumes, diffusing capacity and blood gases, according to Mr. Wanger.

The book's first edition was released in 1992, and the second in 1996. This new edition offers readers new and expanded chapters on testing techniques and guidelines from the American Thoracic Society, the American Association for Respiratory Care, and the European Respiratory Society.

"Having experts like Jack Wanger, whose expertise is demonstrated by the publication of the Third Edition, continues to position PRA as an industry leader in the field of therapeutic expertise and as the industry leader in the area of respiratory clinical development," said Dr. Michael Kirchengast, PRA's Vice President of Scientific Affairs.  

Mr. Wanger has specialized in respiratory therapeutics, pulmonary function testing and pulmonary physiology for more than 40 years. Since joining PRA in 1997, he has been involved in client consulting, protocol development, pulmonary function testing quality assurance, and preparation of clinical study reports and manuscripts. Mr. Wanger has co-authored various society guidelines as a committee member of the American Thoracic Society and American Association for Respiratory Care.  He has received numerous awards honoring and recognizing his commitment, expertise, and contribution to the profession of respiratory care.

PRA's Th
'/>"/>

SOURCE PRA
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. European Experts Recommend Pregnant and Nursing Women Take More DHA - Every Day
2. Seriously Low Vaccination Rates Cause Experts to Call for Increased Immunization Before Influenza Season Peaks
3. Experts Call for Widespread Use of Memory Screenings and Emphasize Value of Early Detection of Dementia
4. Health Experts and Families Encourage Annual Childhood Flu Vaccination to Reduce Flu-Related Illnesses and Deaths in Children
5. Vical Receives NIH Grant for an Immunotherapeutic Herpes DNA Vaccine; Herpes Experts at University of Washington and University of Texas to Conduct Preclinical Development
6. Join NPRs David Ewing Duncan, Author Jessica Queller and a Panel of Medical and Legal Experts in a 90-Minute Webcast on Genetic Testing, Genomic Medicine and Breast & Ovarian Cancer
7. Heart Patients More Likely to Adopt Healthy Habits in 3-Year Program Led by Cardiac Rehabilitation Experts, Mayo Clinic Research Shows
8. Promise of Vicals CMV Vaccine Noted by Independent Experts
9. Kendle Experts to Present at the Drug Information Association 44th Annual Meeting
10. Cytels Clinical Innovation Experts Cyrus Mehta and Judith Quinlan Reveal Latest Adaptive Trial Successes at 44th Annual DIA Meeting
11. Despite Advances in the Accuracy of CT Colonography in Detecting Polyps, Digestive Health Experts Urge Patients to Consider Risks and Realities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... Future Prospects for Companies in Antihistamines, Corticosteroids, ... - new study showing you trends, partnerships, and ... allergic rhinitis drugs heading? What are the commercial prospects ... you potential revenues and other trends to 2025, discussing ... report provides 273 tables, charts, and graphs. Discover the ...
(Date:9/4/2015)... , Sep. 04, 2015 ... of the "Investigation Report on China,s Sodium Ibandronate Market, ... and used in the clinic under the trade name of ... Austria in 1996, sodium ibandronate was approved by ... treatment of osteoporosis under the trade name of Boniva. However, ...
(Date:9/4/2015)... September 4, 2015 Hutchison ... that Hutchison MediPharma Limited ("HMP"), its drug R&D ... second proof-of-concept ("POC") trial of fruquintinib in patients ... in China .  The top-line ... meeting the primary efficacy endpoint of progression free ...
Breaking Medicine Technology:Allergic Rhinitis Drugs Market Forecast 2015-2025 2Allergic Rhinitis Drugs Market Forecast 2015-2025 3Allergic Rhinitis Drugs Market Forecast 2015-2025 4Allergic Rhinitis Drugs Market Forecast 2015-2025 5Allergic Rhinitis Drugs Market Forecast 2015-2025 6Allergic Rhinitis Drugs Market Forecast 2015-2025 7Investigation Report on China's Sodium Ibandronate Market 2010-2019 2Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 2Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 3
... Late Stage Clinical Therapeutic Cancer... -- TUEBINGEN, Germany, September 21, 2010 ... ... ... ,; var first_result; // Results are keyed by longUrl, so we need to grab the first one. ...
... Inc., today announced that it reported positive preclinical ... Association for the Study of Diabetes (EASD).  CCX140, ... the chemokine receptor CCR2, improved metabolic function while ... in an animal model, and was well tolerated ...
Cached Medicine Technology:immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 2immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 3immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 4immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 5immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 6immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 7immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 8immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 9immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 10ChemoCentryx Reports Positive Results and Completion of Phase I Clinical Studies of Novel CCR2 Antagonist, CCX140, at the European Association for the Study of Diabetes (EASD) 2ChemoCentryx Reports Positive Results and Completion of Phase I Clinical Studies of Novel CCR2 Antagonist, CCX140, at the European Association for the Study of Diabetes (EASD) 3ChemoCentryx Reports Positive Results and Completion of Phase I Clinical Studies of Novel CCR2 Antagonist, CCX140, at the European Association for the Study of Diabetes (EASD) 4
(Date:9/4/2015)... Valley Forge, PA (PRWEB) , ... September 04, 2015 , ... ... mold growth in and around the home is quite common. Mold can grow anywhere ... as areas around leaking pipes. Checking for excessive moisture and water in the home ...
(Date:9/4/2015)... ... September 04, 2015 , ... Mike Day, a former Navy SEAL who was ... Ironman World Championships in Kona on October 10th. , Mike is running the race ... through combat and the cutting-edge treatments that restore their quality of life. ...
(Date:9/4/2015)... CA (PRWEB) , ... September 04, 2015 , ... The ... was ranked number 9 nationwide by Doximity. Faculty, residents and staff are ... take great pride in the quality of our ophthalmology residency program. Our faculty places ...
(Date:9/4/2015)... ... September 04, 2015 , ... ECC ... first neighborhood created specifically for adults with intellectual, developmental and acquired disabilities. The ... and feature 30 cottage or “pocket” homes. In this community, adults will live ...
(Date:9/4/2015)... ... September 04, 2015 , ... Compliance officers deal ... under the Stark physician self-referral law. “Stark Law DOs and DON’Ts: Best ... Information Services, Inc. (AIS), will detail which deals are attracting the most government ...
Breaking Medicine News(10 mins):Health News:September is Mold Awareness Month 2Health News:September is Mold Awareness Month 3Health News:September is Mold Awareness Month 4Health News:Navy SEAL Shot 27 Times Competes in Ironman World Championship in Kona to Raise Money for Veteran's Suffering from TBI and PTSD 2Health News:USC Ophthalmology Residency Program Ranked in Top 10 by Doximity 2Health News:USC Ophthalmology Residency Program Ranked in Top 10 by Doximity 3Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 2Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 3Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 4Health News:Sept. 17 Webinar to Offer Best Practices for Physician Contracts 2
... to a tendon can signal an end to their ... in part by University of Southern California (USC) School ... within the adult tendon that have stem-cell characteristicsincluding the ... was able to isolate these cells and regenerate tendon-like ...
... STANFORD, Calif. - Researchers at the Stanford University School ... aglow tumor cells within living animals. Their goal is ... treatment of cancer and other diseases. , The probe,s ... - protein-destroying enzymes - that run amok in cancerous ...
... the National Press,Club,s 10th Annual 5K race today, which ... & F in Washington, Weiner Public News was first ... and op-ed writing,division of Robert Weiner Associates Public Affairs ... 100 papers since Weiner left the White,House in 2001 ...
... monitor eyesight carefully , , SATURDAY, Sept. 8 (HealthDay ... eyesight problems, which can appear gradually and worsen over ... properly monitored, eyesight deterioration can lead to other long-term ... eye exams every year. Changes in vision will not ...
... 7 Rocky Vista,University College of Osteopathic ... colleges of osteopathic medicine in the United ... in Colorado, has been granted provisional,accreditation from ... Accreditation (AOA-COCA). The provisional accreditation,will allow the ...
... to offset higher material prices. ... million in the year., ST. LOUIS, Sept. 7 ... net income increased 38,percent to $869,000, or 11 cents per ... or 8 cents per share, for the fourth,quarter last year. ...
Cached Medicine News:Health News:USC researcher identifies stem cells in tendons that regenerate tissue in animal model 2Health News:Molecular probe 'paints' cancer cells in living animals, Stanford researchers find 2Health News:Molecular probe 'paints' cancer cells in living animals, Stanford researchers find 3Health News:Weiner Public News First Media Team at National Press Club 5K 2Health News:Poor Senior Vision Often a Window on Disease 2Health News:Colorado Medical School Receives Provisional Accreditation 2Health News:Colorado Medical School Receives Provisional Accreditation 3Health News:Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006 2Health News:Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006 3Health News:Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006 4Health News:Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006 5
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: